Abstract
The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Current Genomics
Title: Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway
Volume: 6 Issue: 6
Author(s): S. H. Slofstra and H. T. Cate
Affiliation:
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Abstract: The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Export Options
About this article
Cite this article as:
Slofstra H. S. and Cate T. H., Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482963
DOI https://dx.doi.org/10.2174/138920205774482963 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nucleotide-Derived Thrombin Inhibitors: A New Tool for an Old Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa
Current Pharmaceutical Design The Impact of Coagulation and Fibrinolysis Cascades on the Development of Septic and Autoimmune Arthritis
Current Rheumatology Reviews Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
Current Alzheimer Research The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report
Current Drug Safety Novel Integrin-Specific Targets for Anti-Platelet Therapies
Current Pharmaceutical Design Fetal and Obstetric Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular Disease
Current Pharmaceutical Design Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry Pathophysiology and Pharmacologic Treatment of Venous Thromboembolism
Current Drug Targets Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets
Current Pharmaceutical Design Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Development of Monoclonal Antibodies that Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs
Cardiovascular & Hematological Disorders-Drug Targets New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents
Current Medicinal Chemistry Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Molecular Pathophysiology of Cavernous Nerve Injury and Identification of Strategies for Nerve Function Recovery After Radical Prostatectomy
Current Drug Targets A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery The Relationship Between Inflammation, Platelet Activation and Antiplatelet Resistance
Inflammation & Allergy - Drug Targets (Discontinued)